The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.
Although major guidelines uniformly recommend iron supplementation and erythropoietin stimulating agents (ESAs) for managing chronic anemia in persons with chronic kidney disease (CKD), there are differences in the recommended hemoglobin (Hb) treatment target and no guidelines consider the costs or...
Main Authors: | Benjamin O Yarnoff, Thomas J Hoerger, Siobhan A Simpson, Meda E Pavkov, Nilka R Burrows, Sundar S Shrestha, Desmond E Williams, Xiaohui Zhuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4942058?pdf=render |
Similar Items
-
Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study.
by: Benjamin O Yarnoff, et al.
Published: (2018-01-01) -
Long-term mortality among kidney transplant recipients with and without diabetes: a nationwide cohort study in the USA
by: Ann L Albright, et al.
Published: (2021-08-01) -
ANEMIA IN CHILDREN WITH CHRONIC KIDNEY DISEASE
by: T.E. Pankratenko, et al.
Published: (2011-06-01) -
ANEMIA IN CHILDREN WITH CHRONIC KIDNEY DISEASE
by: T.E. Pankratenko, et al.
Published: (2011-06-01) -
Estimation of chronic kidney disease incidence from prevalence and mortality data in American Indians with type 2 diabetes.
by: Pavithra Vijayakumar, et al.
Published: (2017-01-01)